<b>Full Title</b><br> Protocol 12-245: Genomic Profiling in Cancer Patients <br><br> <b>Description</b><br> Genetic testing for patients with a cancer diagnosis or that are undergoing a work up to establish a potential cancer diagnosis. The primary objective of the trial is to determine the frequency of “actionable” oncogenic mutations in patients with solid or hematologic cancers being evaluated for treatment. <br><br> <b>Contact</b><br> For more information about this or any other study, please contact the NYCBS Research Department:<br> Email: <a href="mailto:ResearchRecruitment@nycancer.com">ResearchRecruitment@nycancer.com</a><br> Telephone: <a href="tel:631-675-5075">631-675-5075</a><br> HALO Messaging App: "Research Team"